节点文献

Xp11易位相关性肾细胞癌的研究进展

Research progress in Xp11 translocation renal cell carcinoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 杨博孙保存

【Author】 Bo Yang;Baocun Sun;Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer;Department of Pathology, Tianjin Medical University;Department of Pathology Tianjin Medical University General Hospital;

【通讯作者】 孙保存;

【机构】 天津医科大学肿瘤医院病理科国家肿瘤临床医学研究中心天津市肿瘤防治重点实验室天津市恶性肿瘤临床医学研究中心天津医科大学病理教研室天津医科大学总医院病理科

【摘要】 Xp11易位相关性肾细胞癌是存在TFE3基因易位的一种罕见肾细胞癌,与t(6;11)易位相关性肾细胞癌共同归类为MiT家族易位相关性肾细胞癌。随着免疫组织化学法、荧光原位杂交法、逆转录-聚合酶链反应以及RNA测序技术的发展和应用,越来越多的Xp11易位相关性肾细胞癌被诊断和研究,从而对于其在临床病理学、分子遗传学、临床治疗方面有了许多新的认识和进展。本文就近年来Xp11易位相关性肾细胞癌的研究进展进行综述。

【Abstract】 Xp11 translocation renal cell carcinoma is a rare renal cell carcinoma subtype harboring a TFE3 translocation, which is grouped into the MiT family translocation renal cell carcinomas together with t(6;11) translocation renal cell carcinomas. With the development and application of immunohistochemistry, fluorescence in situ hybridization, reverse transcription-polymerase chain reaction, and RNA sequencing, increasingly more Xp11 translocation renal cell carcinomas have been diagnosed and studied, and many new insights have been elucidated and advances have been made in clinicopathology, molecular genetics, and clinical treatment. The latest progress in Xp11 translocation renal cell carcinoma research is introduced and reviewed in this paper.

【关键词】 肾细胞癌Xp11基因易位TFE3
【Key words】 renal cell carcinomaXp11 translocationTFE3
  • 【文献出处】 中国肿瘤临床 ,Chinese Journal of Clinical Oncology , 编辑部邮箱 ,2019年08期
  • 【分类号】R737.11
  • 【被引频次】5
  • 【下载频次】178
节点文献中: 

本文链接的文献网络图示:

本文的引文网络